Detection of Cross-Sample Contamination in Multiple Myeloma Samples and Sequencing Data

  • Owen W. Stephens
  • Tobias Meißner
  • Niels WeinholdEmail author
Part of the Methods in Molecular Biology book series (MIMB, volume 1792)


The increasing applicability and sensitivity of next generation sequencing methods exacerbate one of the main issues in the molecular biology laboratory, namely cross-sample contamination. This type of contamination, which could massively increase the rate of false-positive calls in sequencing experiments, can originate at each step during the processing of multiple myeloma samples, such as CD138-selection of tumor cells, RNA and DNA isolation or the processing of sequencing libraries. Here we describe a Droplet Digital PCR (ddPCR) method and a simple bioinformatic solution for the detection of contamination in patient’s samples and derived sequencing data, which are based on the same principle: detection of alternative alleles for single-nucleotide polymorphisms (SNPs) that are homozygous according to the control (germ line) sample.

Key words

Multiple myeloma Cross-sample contamination SNP-based assay Droplet digital PCR Bioinformatics solution 



This work was supported by the National Institute Of General Medical Sciences of the National Institutes of Health under Award Number P20GM125503. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.


  1. 1.
    Rasche L, Chavan SS, Stephens OW, Patel PH, Tytarenko R, Ashby C et al (2017) Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing. Nat Commun 8:268CrossRefGoogle Scholar
  2. 2.
    Bolli N, Avet-Loiseau H, Wedge DC, Van Loo P, Alexandrov LB, Martincorena I et al (2014) Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nat Commun 5:2997CrossRefGoogle Scholar
  3. 3.
    Lohr JG, Stojanov P, Carter SL, Cruz-Gordillo P, Lawrence MS, Auclair D et al (2014) Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy. Cancer Cell 25:91–101CrossRefGoogle Scholar
  4. 4.
    Meißner T, Seckinger A, Rème T, Hielscher T, Möhler T, Neben K et al (2011) Gene expression profiling in multiple myeloma—reporting of entities, risk, and targets in clinical routine. Clin Cancer Res 17:7240–7247CrossRefGoogle Scholar
  5. 5.
    Tirosh I, Izar B, Prakadan SM, Wadsworth MH 2nd, Treacy D, Trombetta JJ et al (2016) Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352:189–196CrossRefGoogle Scholar
  6. 6.
    Macosko EZ, Basu A, Satija R, Nemesh J, Shekhar K, Goldman M et al (2015) Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell 161:1202–1214CrossRefGoogle Scholar
  7. 7.
    Hu H, Liu X, Jin W, Hilger Ropers H, Wienker TF (2015) Evaluating information content of SNPs for sample-tagging in re-sequencing projects. Sci Rep 5:10247CrossRefGoogle Scholar
  8. 8.
    Pengelly RJ, Gibson J, Andreoletti G, Collins A, Mattocks CJ, Ennis S (2013) A SNP profiling panel for sample tracking in whole-exome sequencing studies. Genome Med 5:89CrossRefGoogle Scholar
  9. 9.
    Rajeevan H, Soundararajan U, Kidd JR, Pakstis AJ, Kidd KK (2012) ALFRED: an allele frequency resource for research and teaching. Nucleic Acids Res 40:D1010–D1015CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Owen W. Stephens
    • 1
  • Tobias Meißner
    • 2
  • Niels Weinhold
    • 1
    Email author
  1. 1.The Myeloma InstituteUniversity of Arkansas for Medical SciencesLittle RockUSA
  2. 2.Department of Molecular and Experimental MedicineAvera Cancer InstituteSioux FallsUSA

Personalised recommendations